Alternatives to Biolojic Design, Ltd.

AI-powered drug discovery and development platform for biologics.

Develops and manufactures biologics for therapeutic applications.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

AI-powered platform for antibody discovery and development to create new medicines.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Leveraging the adaptive immune system to diagnose and treat disease.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

AI-powered platform for personalized cell therapy development and manufacturing.

Advance every cancer decision.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

AI-powered platform for designing novel molecular structures for new medicines.

Biotechnology company

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

AI-powered platform accelerating biological research and drug discovery.

Valthos is an applied biological intelligence company. We develop and deploy software and AI methods to outsmart biological evolution and ensure that these tools are deployed to safeguard humanity.

Designs and creates novel enzymes for sustainable and cost-effective bioproduction.

AI-powered biotech platform using protein design to discover novel therapeutic molecules for hard-to-treat targets.

Compressing biology to develop the next generation of therapies.

Narya Bio is developing novel therapeutic antibodies for challenging diseases.

Computational biology company revolutionizing life sciences product discovery and development using predictive biology.

Synthetic biology startup optimizing gene expression for food and biotech applications.

AI-enabled technology for cell biology research and biopharma development.

A global oncology company developing and commercializing innovative cancer treatments.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Vital Bio is developing a novel platform for rapid, high-throughput screening of biological molecules.

AI-driven drug discovery platform for rapid development of novel therapeutics.

Teknova provides critical reagents for biopharmaceutical product development and production.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Mapping cell-cell communication at scale in human tissue.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

Developing novel protein engineering tools for advanced biomanufacturing and therapeutics.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Vexxel is developing a novel platform for cell-free protein synthesis and engineering.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Gene therapy company developing treatments for rare inherited diseases.

Mining biological information for transformative peptide medicines.

Gene therapy company developing transformative treatments for severe genetic diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

AI-powered drug discovery platform for GPCR targets, accelerating development and reducing risk.

Global marketplace connecting researchers with human biospecimens for life science research.

Tech.Bio company advancing mRNA discovery with AI and its mRNA Lightning platform.